MONOFERRIC

This brand name is authorized in Canada, United States

Active ingredients

The drug MONOFERRIC contains one active pharmaceutical ingredient (API):

1 Ferric derisomaltose UNII AHU547PI9H - FERRIC DERISOMALTOSE

Ferric derisomaltose is a complex of iron (III) hydroxide and derisomaltose, an iron carbohydrate oligosaccharide that releases iron. Iron binds to transferrin for transport to erythroid precursor cells to be incorporated into hemoglobin. It is used for the treatment of iron deficiency anemia (IDA) in adult patients.

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MONOFERRIC Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B03AC	Iron trivalent, parenteral preparations	B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations
Discover more medicines within B03AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02477777
Country: US	FDA, National Drug Code	Identifier(s): 73594-9301, 73594-9305, 73594-9310